Cannabis Flashcards

1
Q

What are the medical indications of Marijuana (5)

A

decrease N/V in chemotherapy

alleviates chronic pain (questions on safety and effectiveness)

Neurological Problems (subjective relief for MS, epilepsy and Huntingdon’s)

increase appetite in HIV patients

PTSD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What did the Henquet et Al 2005 paper prove?

A

a link between cannabis and schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the synthesis and metabolism of THC molecule (3)

A

made from cannabidiol into THC

THC is then converted into II-hydroxy THC which is a more active form that is highly lipophilic

or its converted into cannabiol which is the inactive metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the natural agonists and partial agonists to CB receptors? (3)

A

cannabidiol and THC are natural agonists

AEA - anandimide is a partial agonist

2-AG - 2-arachidanoyl glycerol - full agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is AEA synthesised? (2)

A

PLD binds to NAPE to form a complex

high Ca+ stimulates AEA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is 2-AG synthesised? (2)

A

precursor is hydrolysed

DAGL and DAGL B hydrolyse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the stimuli for CB agonist production? (2)

A

increased concentation of phospholipid precursors

activation of GPCR, PLC and increased Ca+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where are agonists produced? (4)

A

neurons, astrocytes and microglia

cardiac myocytes and blood vessels

vascular wall

gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why are endocannabinoids not neurotransmitters? (1)

A

they are not pre-synthesised and stored in vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the degradation processes of both AEA and 2-AG including the enzymes, pathways and studies supporting them. (8)

A
AEA becomes 
arachidonic acid and ethanulamine 
by FAAH in the 
COX pathway
Kathuria 2002
2-AG becomes 
arachidonic acid and glycerol 
by MGL in the 
COX pathway
Maccarone 2008
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the function of CB1 agonists and antagonists in the hippocampus (2)

A

CB1 decreases spontaneous IPSP of GABAergic interneurons (causes inhibition)

antagonists block depolarisation-induced suppression of inhibition (DSI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the therapeutic potentials of endocannabinoids based on their brain locations (7)

A

Basal Ganglia and cerebellum - motor function

hippocampus - learning and memory

cerebral cortex - high cognitive function

hypothalamus - thermal regulation, neuroendocrine regulation, appetite, depression and anxiety

amygdala - emotionality

spinal cord - peripheral sensation and pain

brain stem - N&V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the evolution of CB receptors among species (7)

A

Plants have no CB or CBr
eCB homologues present

C. Elegans have no CB
eCB’s and FAAH

Insects have no CB, FAAH or NAPE-PLD
but they have 2-AG and DAGL

Vertebrates have CB1, CB2, NAPE-PLD, DAGL-B and those stated above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the effect of CB1 on neurotransmission (4)

A

CBs are activated via DSI.

DSI occurs in hippocampal pyramidal cells, when cells are depolarised they suppress GABA-mediated inhibition

DSI is blocked by CB1 antagonist rimonobant

location of CB1 receptors and distribution of DAG-lipase and MAG-lipase fit idea that 2-AG could be a retrograde messenger in DSI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the differences between AEA, DEA and PEA? (1)

A

DEA and PEA act to inhibit CB1 and CB2 but are alike AEA in structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the main side effects of endocannabinoids? (3)

A

hypothermia

hypomotility

catolepsy - seizure, loss of sensation and consciousness

17
Q

What are the alternative targets for endocannabinoid signalling? (4)

A

TRPV1 - Transient Receptor Potential Vanilloid Receptor - sensory neurons in the brain and epithelium

PPAR - Peroxisome Proliferator-activated receptor
adipocytes, macrophages, blood vessels and neurons

K+ channels
Kc, Kv and TASK1

Ca++ channels
T-type Ca+ channels